Replies to post #656457 on NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

I never told you there was anything to see at the current time. I do know there are rules in the U.K. So I could not tell you if those impact in any way their ability to recognize revenues prior to approval. But the relationship between the companies is laid out in the financials, I am not here to educate you. Not my job. Children should not be playing with daddy’s money, until they know a bit more. You know where the financials are.

[exwannabe]

Simple question Bio: Give me the numbers for revenue from specials.

There is a real answer and a fanatsy answer,

Real answer is $370K for last Q. (the $406k top line - the $36k sublease that is also revenue)

Fantasy answer is that Advent is receiving the cash and NWBO only reports what they get out of that. This is nonsense as it would be crossing a very bright line on financial reporting. Just like all the other Advent terms are reported, this would need to be also,.

Back to real world, one thing Bio is correct on is that they very likely are selling at discounts as needed. This is nearly universal in the space here in the US, and I would expect similar for Specials. But even at a discount this is not much.